on MAAT PHARMA (isin : FR0012634822)
Symbiosis LLC Reduces Stake in MAAT PHARMA
On October 3, 2025, it was revealed that Symbiosis LLC had reduced its stake in MAAT PHARMA, a company listed on Euronext Paris. On July 15, 2025, Symbiosis LLC fell below the 10% share capital and voting rights thresholds, holding 9.93% of the shares. This figure was reduced to 4.76% on September 11, 2025, following a further share sale.
This move is part of Symbiosis LLC's regular market adjustments, controlled by Chidozie Ugwumba. It now holds 1.04% of MAAT PHARMA's capital and voting rights, or 168,514 shares. These transactions reflect a significant reduction in Symbiosis LLC's involvement in the company.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MAAT PHARMA news